Ayyolath A

References (2)

Title : Investigating the disease-modifying properties of sclerotiorin in Alzheimer's therapy using acetylcholinesterase inhibition - Ayyolath_2023_Chem.Biol.Drug.Des__
Author(s) : Ayyolath A , Kallingal A , Kundil VT , Suresh AM , Jayadevi Variyar E
Ref : Chemical Biology Drug Des , : , 2023
Abstract : Ayyolath_2023_Chem.Biol.Drug.Des__
ESTHER : Ayyolath_2023_Chem.Biol.Drug.Des__
PubMedSearch : Ayyolath_2023_Chem.Biol.Drug.Des__
PubMedID: 37076430

Title : Divulging the anti-acetylcholinesterase activity of Colletotrichum lentis strain KU1 extract as sustainable AChE active site inhibitors - Kallingal_2022_Arch.Microbiol_204_713
Author(s) : Kallingal A , Ayyolath A , Thachan Kundil V , Maniyeri Suresh A , Muringayil Joseph T , Haponiuk J , Thomas S , Augustine A
Ref : Arch Microbiol , 204 :713 , 2022
Abstract : Kallingal_2022_Arch.Microbiol_204_713
ESTHER : Kallingal_2022_Arch.Microbiol_204_713
PubMedSearch : Kallingal_2022_Arch.Microbiol_204_713
PubMedID: 36396887